GANDOLFI, LISA
 Distribuzione geografica
Continente #
NA - Nord America 636
EU - Europa 275
AS - Asia 179
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 1.095
Nazione #
US - Stati Uniti d'America 630
IT - Italia 107
SG - Singapore 79
UA - Ucraina 42
CN - Cina 36
HK - Hong Kong 33
DE - Germania 29
FI - Finlandia 20
RU - Federazione Russa 17
IE - Irlanda 15
SE - Svezia 14
TR - Turchia 14
GB - Regno Unito 8
IN - India 7
CA - Canada 5
CZ - Repubblica Ceca 5
FR - Francia 5
JP - Giappone 3
AT - Austria 2
BR - Brasile 2
LV - Lettonia 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BE - Belgio 1
CH - Svizzera 1
ES - Italia 1
GR - Grecia 1
IM - Isola di Man 1
IR - Iran 1
KR - Corea 1
MD - Moldavia 1
MU - Mauritius 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
VN - Vietnam 1
Totale 1.095
Città #
Fairfield 96
Ashburn 58
Singapore 50
Wilmington 49
Chandler 47
Woodbridge 44
Jacksonville 35
Seattle 34
Hong Kong 33
Houston 30
Princeton 29
New York 24
Cambridge 23
Brescia 21
Helsinki 20
Dublin 15
Beijing 14
Istanbul 11
Ann Arbor 9
Boardman 9
Shanghai 9
Los Angeles 7
Milan 7
Moscow 7
Des Moines 6
Genoa 6
Rome 5
Battipaglia 4
Brno 4
Pune 4
Brendola 3
Brooklyn 3
Falkenstein 3
Jinan 3
Kocaeli 3
Munich 3
San Francisco 3
Santa Clara 3
Toronto 3
Viterbo 3
Amsterdam 2
Bergamo 2
Casanova Lonati 2
London 2
Lovere 2
Mumbai 2
Nanjing 2
Pescara 2
Riga 2
San Diego 2
Shenyang 2
São Paulo 2
Tokyo 2
Vicenza 2
Athens 1
Baku 1
Boston 1
Brussels 1
Castiglione Delle Stiviere 1
Catania 1
Chicago 1
Chiswick 1
Civitavecchia 1
Delhi 1
Dhaka 1
Douglas 1
Gossolengo 1
Hebei 1
Hillsborough 1
Kilburn 1
Kish 1
Kōriyama 1
La Spezia 1
Leawood 1
Lequio Tanaro 1
Lima 1
Lisbon 1
Madrid 1
Melbourne 1
Newark 1
Ningbo 1
North York 1
Norwalk 1
Nuremberg 1
Olomouc 1
Padova 1
Panama City 1
Pesaro 1
Redwood City 1
Reston 1
Spoltore 1
Stockholm 1
Tianjin 1
Tiraspol 1
Verona 1
Vienna 1
Yangsan 1
Zurich 1
Totale 812
Nome #
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 135
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 106
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 103
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 96
Advances in CMV Management: A Single Center Real-Life Experience 89
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 81
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 77
OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 65
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 64
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 61
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 58
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 56
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 52
S882 OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 43
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study 37
Totale 1.123
Categoria #
all - tutte 7.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.834


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202088 0 0 0 0 0 0 0 0 23 32 13 20
2020/2021304 5 13 7 52 20 51 21 33 29 38 16 19
2021/2022141 14 6 1 15 4 12 4 9 7 26 11 32
2022/2023153 19 6 5 8 15 30 2 25 16 7 10 10
2023/2024180 12 6 18 11 10 45 9 5 30 1 2 31
2024/2025191 1 12 0 43 27 29 18 20 41 0 0 0
Totale 1.123